Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jun 10:4:72.
doi: 10.3389/fneur.2013.00072. eCollection 2013.

What Renders TAU Toxic

Affiliations

What Renders TAU Toxic

Jürgen Götz et al. Front Neurol. .

Abstract

TAU is a microtubule-associated protein that under pathological conditions such as Alzheimer's disease (AD) forms insoluble, filamentous aggregates. When 20 years after TAU's discovery the first TAU transgenic mouse models were established, one declared goal that was achieved was the modeling of authentic TAU aggregate formation in the form of neurofibrillary tangles. However, as we review here, it has become increasingly clear that TAU causes damage much before these filamentous aggregates develop. In fact, because TAU is a scaffolding protein, increased levels and an altered subcellular localization (due to an increased insolubility and impaired clearance) result in the interaction of TAU with cellular proteins with which it would otherwise either not interact or do so to a lesser degree, thereby impairing their physiological functions. We specifically discuss the non-axonal localization of TAU, the role phosphorylation has in TAU toxicity and how TAU impairs mitochondrial functions. A major emphasis is on what we have learned from the four available TAU knock-out models in mice, and the knock-out of the TAU/MAP2 homolog PTL-1 in worms. It has been proposed that in human pathological conditions such as AD, a rare toxic TAU species exists which needs to be specifically removed to abrogate TAU's toxicity and restore neuronal functions. However, what is toxic in one context may not be in another, and simply reducing, but not fully abolishing TAU levels may be sufficient to abrogate TAU toxicity.

Keywords: Alzheimer’s disease; C. elegans; PP2A; PTL-1; TAU; frontotemporal dementia; knock-out; transgenic.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Neuronal aging in C. elegans is demonstrated by the accumulation of abnormal neuronal structures. Reporter lines expressing GFP in particular neuronal subsets are used to track these phenotypes as animals age. In touch receptor neurons (top), branching from the cell body or axon, as well as beading along the axon, can be observed. In GABAergic motor neurons (bottom), branching from commissures extending dorsally can be visualized. These phenotypes usually accumulate in late adulthood in wild-type animals, but in ptl-1 mutant strains these structures can be seen starting in early to mid-adulthood. Arrows indicate branching, asterisks indicate beading. Scale bar = 50 μ. Ventral is down.

References

    1. Akoury E., Pickhardt M., Gajda M., Biernat J., Mandelkow E., Zweckstetter M. (2013). Mechanistic basis of phenothiazine-driven inhibition of Tau aggregation. Angew. Chem. Int. Ed. Engl. 52, 3511–3515 10.1002/anie.201208290 - DOI - PubMed
    1. Allen R. D., Weiss D. G., Hayden J. H., Brown D. T., Fujiwake H., Simpson M. (1985). Gliding movement of and bidirectional transport along single native microtubules from squid axoplasm: evidence for an active role of microtubules in cytoplasmic transport. J. Cell Biol. 100, 1736–1752 10.1083/jcb.100.5.1736 - DOI - PMC - PubMed
    1. Arendt T. (2009). Synaptic degeneration in Alzheimer’s disease. Acta Neuropathol. 118, 167–179 10.1007/s00401-009-0536-x - DOI - PubMed
    1. Arriagada P. V., Growdon J. H., Hedley-Whyte E. T., Hyman B. T. (1992). Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer’s disease. Neurology 42, 631–639 10.1212/WNL.42.3.631 - DOI - PubMed
    1. Bhaskar K., Hobbs G. A., Yen S. H., Lee G. (2010). Tyrosine phosphorylation of tau accompanies disease progression in transgenic mouse models of tauopathy. Neuropathol. Appl. Neurobiol. 36, 462–477 10.1111/j.1365-2990.2010.01103.x - DOI - PMC - PubMed